Associated Papers
The impacts of natural product miltirone and the CYP2D6 pharmacogenetic phenotype on fluoxetine metabolism.
Zhang X et al.
Frontiers in Pharmacology, 2024
Effect of 22 CYP2D6 variants found in the Chinese population on tolterodine metabolism in vitro.
Wang H et al.
Chemico-biological Interactions, 2017
In vitro assessment of 24 CYP2D6 allelic isoforms on the metabolism of methadone.
Su Y et al.
Drug Testing and Analysis, 2017
Effect of 22 Novel Cytochrome P450 2D6 (CYP2D6) Variants Found in the Chinese Population on Hemangeol Metabolism In Vitro.
Liang B et al.
European Journal of Drug Metabolism and Pharmacokinetics, 2016
Evaluation of 24 CYP2D6 Variants on the Metabolism of Nebivolol In Vitro.
Hu X et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals, 2016
Effects of 22 Novel CYP2D6 Variants Found in the Chinese Population on the Bufuralol and Dextromethorphan Metabolisms In Vitro.
Cai J et al.
Basic & Clinical Pharmacology & Toxicology, 2016
Effect of CYP2D6 variants on venlafaxine metabolism in vitro.
Zhan YY et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems, 2016
Effects of 22 novel CYP2D6 variants found in Chinese population on the metabolism of dapoxetine.
Xu RA et al.
Drug Design, Development and Therapy, 2016
Effects of 22 CYP2D6 Genetic Variations Newly Identified in Chinese Population on Olanzapine Metabolism in vitro.
Zhou HY et al.
Pharmacology, 2016
Role of cytochrome P450 2D6 genetic polymorphism in carvedilol hydroxylation in vitro.
Wang Z et al.
Drug Design, Development and Therapy, 2016
Select a paper to view details